Skip to content

Dossier · ENTG · Dormant

ENTG · Entegris, Inc. · Stock research

Last analysed ·

Current thesis

June's sentiment re-rate rolled over; the 2026-08-04 beat-and-raise re-based the story on numbers — Q2 sales $883.2M vs $835.5M consensus, Q3 guide $905–935M vs $879.8M — and drew three target raises on 08-05 (UBS $215). At $152.08 the stock is still 17.3% under the June high, so the earnings-confirmed leg has not been re-priced.

Invalidation trigger

A weekly close below $140 erases the 2026-08-04 post-print advance and returns price to the pre-earnings July range; secondarily, Q3 sales tracking under the $905M guide floor at the ~2026-10-28 (est.) print, or the WFE cohort rolling to SATURATED.

Thesis status

Open commitment catalyst in 4dscored if the trigger above fires How this is scored →

Latest analysis and events for ENTG —

As of 2026-08-08, orbyd's latest analysis for Entegris, Inc. (ENTG): June's sentiment re-rate rolled over; the 2026-08-04 beat-and-raise re-based the story on numbers — Q2 sales $883.2M vs $835.5M consensus, Q3 guide $905–935M vs $879.8M — and drew three target raises on 08-05 (UBS $215). At $152.08 the stock is still 17.3% under the June high, so the earnings-confirmed leg has not been re-priced.

Invalidation trigger: A weekly close below $140 erases the 2026-08-04 post-print advance and returns price to the pre-earnings July range; secondarily, Q3 sales tracking under the $905M guide floor at the ~2026-10-28 (est.) print, or the WFE cohort rolling to SATURATED.

Next dated event on file: — catalyst in 4d.

Current Thesis

The leg that carried this name in June — a sentiment re-rate on the 2026-05-27 JSR/Inpria EUV cross-license, Mizuho's 2026-05-29 raise to $180 and back-to-back CNBC "Final Trades" mentions on 06-04 and 06-05 — ran to roughly $181 and then rolled over. Price spent July giving that back. The 2026-08-04 Q2 print re-based the story on reported numbers: net sales $883.2M against $835.5M consensus and above the company's own $815–845M guide from 2026-04-30, non-GAAP EPS $0.93 versus $0.82, and a Q3 guide of $905–935M sales / $0.96–1.04 non-GAAP EPS against $879.8M and $0.93 consensus. Coverage of the release put Q2 sales up 11.5% year over year, a step up from the +5% posted in Q1 on 2026-04-30. Three houses moved on 2026-08-05: UBS reiterated Buy and lifted its target to $215, Oppenheimer upgraded to Outperform with $180, Needham reiterated Buy at $170. Shares jumped roughly 9% on the results per Investing.com's earnings-call coverage. What an investor is buying now is a wafer-fab-equipment upcycle expressed through a unit-driven consumables supplier whose numbers finally caught the multiple — while the 2026-08-07 close of $152.08 sits 17.3% below the $183.84 52-week high. The re-rate has been earned on paper and not yet re-priced.

Bullish and bearish views on Entegris, Inc.

The model's bull view on Entegris, Inc. (ENTG), in brief: The print cleared its own guide, not just consensus. The bear view: Price did not confirm the beat. The 2026-08-07 close of $152.08 is 17.3% under the $183.84 52-week high, and the three-month return is +2.1% — a full round trip through the June spike with nothing to show for it. A beat-and-raise that leaves the stock nearly a fifth below its… Both cases follow in full.

Bull Case

  • The print cleared its own guide, not just consensus. Q2 2026 net sales $883.2M topped the $815–845M range issued with Q1 on 2026-04-30; non-GAAP EPS $0.93 versus $0.82 consensus (results 2026-08-04).
  • The guide moved the forward number up. Q3 2026 sales guided to $905–935M against $879.8M consensus, with the quarter ending 2026-09-26; non-GAAP EPS $0.96–1.04 versus $0.93; GAAP EPS $0.75–0.83 versus $0.69 (2026-08-04).
  • Growth rate inflected. Coverage of the Q2 release reported sales +11.5% YoY, against the +5% YoY printed in Q1 2026 ($811.9M, reported 2026-04-30). The mid-single-digit grower objection from the June leg is weaker on this datapoint.
  • Margin and cash quality improved with the volume. The Q2 release and call coverage cite the highest adjusted gross margin since early 2022, free cash flow of $120M (14% of sales), an additional $200M of debt repaid and net leverage of 3.4x (2026-08-04). Q1 comparatives: adjusted gross margin 44.6%, adjusted EBITDA $225.6M, free cash flow $141.5M.
  • The sell-side range re-set upward the next morning. UBS $215, Oppenheimer upgrade to Outperform $180, Needham $170, all dated 2026-08-05 — against a July slate of Mizuho $200 (07-01), BMO $167 (07-06) and Deutsche Bank Hold $155 (07-06). The high end of the range now sits far above the 52-week high.
  • Content per wafer keeps compounding. Gate-all-around, high-NA EUV and advanced packaging each lift materials intensity; the 2026-05-27 Inpria cross-license removes a metal-oxide resist legal overhang for next-generation lithography chemistry.

Bear Case

  • Price did not confirm the beat. The 2026-08-07 close of $152.08 is 17.3% under the $183.84 52-week high, and the three-month return is +2.1% — a full round trip through the June spike with nothing to show for it. A beat-and-raise that leaves the stock nearly a fifth below its high says supply is meeting the news.
  • The upgrade cluster is concentrated in one session. Three target moves on 2026-08-05 arrived after the print. Post-event target raises follow price and rarely create the next buyer.
  • The balance sheet still carries acquisition leverage. Net leverage of 3.4x after repaying $200M in Q2 (2026-08-04) keeps deleveraging ahead of buyback flexibility; capital return is a $0.10 quarterly dividend (declared 2026-07-15, payable 2026-08-19).
  • No offsetting open-market purchase has appeared in filings coverage through 2026-08-07.
  • The demand base is capex, and capex is decided elsewhere. Volumes key off leading-edge foundry and memory spending at TSMC, Samsung, Intel and the HBM makers, plus export-control treatment of advanced materials into China. Neither variable is company-controlled.

Setup & Price Structure

  • Life-cycle label: MATURING. Well known since the CNBC Final Trades on 2026-06-04 and 06-05; still working, as the 2026-08-04 print and the 2026-08-05 target raises show; but flow is moderating — three months of net-flat price (+2.1%) around a spike to ~$181 and back. The name is not fresh, it has not broken, and the marginal bid is thinner than it was in mid-June.
  • Momentum is mid-range. RSI(14) at 60.2 on the 2026-08-07 close of $152.08 — the reading of a stock that has gapped up inside a larger correction rather than one at the end of a vertical leg.
  • Levels that matter. The mid-June breakout shelf and the rising 20-EMA converged near $150; price closed 2026-08-07 at $152.08, just above it, with the post-print gap from 2026-08-04 underneath. Overhead supply sits between the mid-$160s and the June high near $181, then the 52-week high at $183.84.
  • Crowding/positioning observables. Retail-attention coverage clustered in June (CNBC 06-04, 06-05; whale/unusual-options flags 06-17 and 07-02) and has not re-clustered post-print in news flow through 2026-08-07. Distance above the rising 20-EMA is small. The nearest company-specific binary — the Q3 print — is roughly eleven weeks out, so there is no imminent earnings blackout. Insider activity in the record is one-directional selling from May–June with no purchases.
  • What price has to do. Reclaiming the mid-$160s on a weekly basis would show the earnings-confirmed leg is being repriced. Failing to hold the post-print range keeps the name a range trade inside a broken June structure.

Catalyst Calendar (next 30 days)

  • 2026-08-13 — Applied Materials fiscal Q3 2026 results and call (confirmed by AMAT IR). The cohort read-through: leading-edge capex commentary and October-quarter guidance set the tone for WFE-linked consumables demand.
  • 2026-08-19 — Quarterly dividend of $0.10/share payable (declared 2026-07-15, record date 2026-07-29). No thesis content beyond confirming capital-return continuity while deleveraging.
  • 2026-09-26 — Fiscal Q3 quarter end. Closes the books on the $905–935M guide; any pre-announcement risk sits after this date.
  • ~2026-10-28 (est.) — Q3 2026 print, outside the 30-day window. Timing estimated from the 2026-04-30 Q1 and 2026-08-04 Q2 reporting cadence. This is the next company-specific binary.

What Would Change Our Mind

The structure that has to hold is the 2026-08-04 gap and the $150 shelf directly beneath the 2026-08-07 close of $152.08 — the same area that capped the July fade. Losing it means the beat-and-raise bought nothing and the June top stands as completed distribution. The gradeable condition: a weekly close below $140 erases the post-print advance and returns price to the pre-earnings July range. Secondarily, Q3 sales tracking below the $905M guide floor at the ~2026-10-28 (est.) print would break the growth-inflection claim the +11.5% YoY Q2 established; and a WFE cohort rolling to SATURATED — Applied Materials guiding its October quarter below consensus on 2026-08-13, or a top-tier foundry trimming 2027 capex — removes the demand premise underneath the consumables story. On the other side, weekly closes back above the mid-$160s would argue the life-cycle label should move rather than the thesis.

Correlation Notes

  • WFE complex beta. ENTG trades with the semiconductor-equipment cohort — the 2026-06-17 session where equipment names led the tape moved this name with them. The 2026-08-13 Applied Materials print is the nearest dated cohort event and will likely set direction for the group into late August.
  • Different revenue physics from the toolmakers. Consumables demand keys off wafer starts and materials content per wafer, so revenue is steadier than tool bookings; the share price nonetheless correlates with SOX-level capex sentiment, which is what produced both the June spike and the July give-back.
  • Memory/HBM capex is the swing variable. The Q2 acceleration was attributed to both unit-driven and capex-related businesses; a memory capex pause would show up in the unit line with a lag rather than immediately.
  • Policy tail. Advanced-materials shipments into China carry export-control sensitivity; any new rule touching that category is a sector-wide event.

Notes

  • Picks-and-shovels consumables: revenue keys off wafer starts and materials content per wafer, steadier than tool bookings at the equipment makers it supplies.
  • Balance sheet still carries acquisition leverage: an additional $200M repaid in Q2, net leverage 3.4x as of the 2026-08-04 release. Deleveraging ranks ahead of buybacks.
  • Fiscal quarters end off-calendar — Q3 2026 ends 2026-09-26 — and results land roughly five weeks after quarter-end (Q2 reported 2026-08-04).
  • Capital return is a $0.10/share quarterly dividend (declared 2026-07-15, record 2026-07-29, payable 2026-08-19); immaterial to the return case.
  • Advanced-materials shipments into China carry standing export-control exposure; rule changes hit the whole materials cohort, not this name alone.
  • Insider record for May–June 2026 shows open-market sales only (SVP 6,848 sh; director James Lederer 3,569 sh) with no disclosed purchases.

Related · shared themes

MU

Micron Technology, Inc.

The 2026-08-03 divergence extended: MU closed $892.67 on 2026-08-04, +21.8% over four sessions, and Counterpoint put Q2 DRAM share at Micron 25% versus SK Hynix 26%. Price remains under a falling 50-day near $958 with no confirmed base; SanDisk's 2026-08-05 print and Micron's 2026-08-10 KeyBanc appearance are the nearest reads.

MEDIUM

SIMO

Silicon Motion Technology Corporation

Controller-mix decoupling got its first hard datapoint on 2026-08-06 — SIMO +8.42% to $267.43 while Western Digital fell 16% and SanDisk 11% on beat-but-guide-light prints — then gave most of it back on 08-07 (-4.23% to $256.12, $18.87 off the high, thinnest volume of the run). Six sessions after a beat-and-raise the ADS sits $1.02 above the 07-30 reaction close; the 50-day at $286.82 is unreclaimed.

MEDIUM

ARM

Arm Holdings plc

Q1 FY27 (2026-07-29) beat, but Q2 royalty growth was guided to ~13% from the 22% delivered, on memory-driven handset weakness. The 2026-08-04 +17.36% snapback to $280.56 lifted price above six of nine published post-print targets and to within 1.7% of the $285.33 consensus average. SoftBank, the controlling holder, reports 2026-08-06.

LOW

MRVL

Marvell Technology, Inc.

Custom-silicon ASIC royalty story intact, but the AI-semi theme is mid-correction — chips posted their worst month vs software on record (7/17) with money rotating into energy. Buying a falling sector with no confirmed higher low is the trap; wait for the $250-255 May shelf to hold before re-engaging.

LOW

See also · stocks to watch